Skip to content

Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05115877
Enrollment
1000
Registered
2021-11-10
Start date
2021-01-07
Completion date
2030-05-17
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Disease

Brief summary

This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.

Detailed description

It is reported in the literature that the treatment of any gastrointestinal disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our treatment of benign or malignant gastrointestinal diseases through medical chart review. There is a need to understand and improve the current diagnosis and treatment algorithm for gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.

Interventions

None listed

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to 2030. * Age ≥18 years

Exclusion criteria

* Patients that are not diagnosed with or treated for gastrointestinal diseases * Age \<18 years

Design outcomes

Primary

MeasureTime frameDescription
Overall survivalJan 2005 - Jan 2030from day of diagnosis or procedure to death date
Overall symptomJan 2005 - Jan 2030Difficulty swallowing, Heartburn, Regurgitation, Chest pain, Weight Loss, Quality of life
MortalityJan 2005 - Jan 2030death or life
MorbidityJan 2005 - Jan 2030yes or no to individual disease

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDhiresh R Jeyarajah

Methodist Health System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026